Find Academic Supervisors

• Cardiac Electrophysiology
• Cardiac Arrhythmias
• Lysosomal Calcium Signaling
• +5 more

Associate Professor Rebecca Burton is a cardiac electrophysiologist in the Department of Pharmacology at the University of Oxford's Medical Sciences Division. Since completing her DPhil in 2006, she has led research on cardiac arrhythmias with focus on lysosomal calcium signaling and hydroxychloroquine's effects on heart rhythm. Her group of approximately 10 researchers employs novel imaging methods and traditional pharmacology techniques to study cardiac function. Her research interests center on cardiac arrhythmia mechanisms, particularly the role of lysosomal calcium stores in atrial fibrillation. She investigates cAMP-Ca 2+ cross talk in atrial nanodomains, IP3 receptor signaling , and acidic organelle function in cardiomyocytes. Her work bridges basic science with translational applications through collaborations with clinicians across disciplines. Her 15 most recent publications (2022-2025) demonstrate consistent focus on lysosomal calcium signaling in cardiac rhythm regulation, with particular emphasis on atrial-specific mechanisms. Key themes include compartmentalized cAMP signaling, NAADP-mediated calcium release, and the role of endolysosomal networks in atrial fibrillation pathophysiology. Scientific recognition includes: Winston Churchill Medal for contributions to Science and Technology (2015-2016) Sir Henry Dale Fellowship supporting her ambitious interdisciplinary research Beyond research, Burton serves in teaching roles including examination setting and marking, provides pastoral care at her college, and actively engages in public outreach through events like the Science Museum Lates. She has advocated for improved career pathways for early-career researchers and greater equality of opportunity in academia. Her laboratory specializes in advanced cardiac optical mapping, lysosomal calcium imaging, and multi-disciplinary approaches to studying the neuro-cardiac axis, with particular focus on how sympathetic neuronal activity affects cardiac conduction and arrhythmia susceptibility.

Mark C. FishmanView profile

Professor

• Cardiovascular Development
• Neurobiology
• Zebrafish Genetics
• +4 more

Mark C. Fishman, M.D., is a Professor of Stem Cell and Regenerative Biology at Harvard University and affiliated with the Harvard Stem Cell Institute. His laboratory investigates the heart-brain axis using zebrafish to map autonomic control circuits and decode the genetic/neuronal basis of vertebrate social behavior . From 2002-2016, he led Novartis Institutes for Biomedical Research, advancing 90 medicines to clinical trials, with a focus on regenerative therapies for aging disorders. Education : Yale College (A.B.), Harvard Medical School (M.D.) Academic Leadership : Former Chief of Cardiology and Director of Cardiovascular Research Center at Harvard Medical School and MGH Research spans cardiovascular development , neurogenetics , and translational medicine , with seminal work on zebrafish genetic screens in the 1990s establishing pathways for vertebrate organ formation. His lab introduced zebrafish as a model for dissecting social interaction circuits and homeostatic regulation . Current work explores how internal sensory systems shape behavior through genetic and pharmacological interventions. Recent publications highlight zebrafish studies on age-related vascular calcification (αKlotho), dopamine transporter mutations (psychiatric models), and collective behavior genetics . Articles span 1996-2025, reflecting continuous contributions to Developmental Biology , Neuroscience , and Cardiovascular Research . Awards include election to the National Academy of Medicine (20-year member), Fellow of the American Academy of Arts and Sciences , and leadership roles in biotech (Aditum Bio, Beam Therapeutics). He authored the textbook Medicine and Lab: Building a Home for Scientists , bridging architectural design with scientific innovation. Teaching includes SCRB 197/297 Frontiers in Therapeutics , examining disease elimination promises and personalized medicine through historical and modern therapeutic frameworks. His lab in Sherman Fairchild Building (Cambridge, MA) continues mentoring interdisciplinary researchers in cardiovascular-neurobiological interfaces.

• Neuroscience
• Astrocyte Biology
• Calcium Signaling
• +5 more

Dr. Baljit S. Khakh is a Professor of Neurobiology and Physiology at the David Geffen School of Medicine, University of California, Los Angeles. He holds the Eleanor I. Leslie Chair of Neuroscience and leads groundbreaking research on astrocyte biology, calcium signaling, and their roles in neural circuits and neurodegenerative diseases. His work integrates optical/genetic tools with proteomic and behavioral studies, funded by multiple NIH grants including R01, R35, and DP1 awards. Research Focus: Astrocyte diversity, calcium signaling, Huntington's disease, Alzheimer's pathology, neural circuit modulation. Key Collaborations: Michael Sofroniew (UCLA), Loren Looger (Janelia), James Wohlschlegel (UCLA), Peyman Golshani (UCLA). Techniques: Genetically-encoded sensors, proximity biotinylation, in vivo calcium imaging, astrocyte-neuron interaction assays. Scientific Awards: Eleanor I. Leslie Chair of Neuroscience

• Ion Transport Physiology
• Molecular Cell Biology
• Biophysics
• +3 more

Thomas J. Jentsch is a leading Professor at the Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP) in Berlin, with secondary affiliation to the Max Delbrück Center (MDC) . He holds dual doctorates in Medicine and Physics from Freie Universität Berlin and has pioneered research in ion transport physiology since co-founding the Center for Molecular Neurobiology Hamburg in 1988. Head of Jentsch Group at FMP since 2006 World leader in chloride channel research His research bridges molecular physiology and human genetics , focusing on: CLC family chloride channels/transporters VRAC/LRRC8 volume-regulated channels ASOR/TMEM206 acid-activated channels Pathologies: neurodegeneration, deafness, osteopetrosis, hypertension Recent work includes breakthroughs in VRAC channel structure (2023) and CLCN7 channelopathies (2024). His lab employs genetically modified mouse models and human mutation analysis to uncover disease mechanisms.

• Epilepsy
• Neurology
• Cognitive Disorders
• +5 more

Arjune Sen is Professor of Global Epilepsy at the University of Oxford, Head of the Oxford Epilepsy Research Group, and Founding Director of the Centre for Global Epilepsy. He serves as a Consultant Neurologist with responsibility for tertiary/quaternary epilepsy care and holds the position of BRC Senior Research Fellow. His work is wholly multidisciplinary, bringing together colleagues and expertise from across the entire University as well as fostering broad international collaboration. Arjune's research focuses on multiple critical areas in epilepsy care and research: Revitalizing academic epileptology in Oxford Cognitive, psychological and psychosocial difficulties in patients with epilepsy Pathways that may cause neurodegeneration in epilepsy Developing treatments that ameliorate both seizures and co-morbidities How epilepsy intersects with other conditions, notably dementia and psychiatric co-morbidity Closing the epilepsy treatment gap, particularly in resource-limited settings Developing culturally contextualized technologies for epilepsy diagnosis at scale Analysis of his recent publications (2023-2025) reveals several key trends in his research. There is a strong focus on the intersection of epilepsy with dementia and cognitive disorders, as evidenced by multiple studies on levetiracetam's effects in Alzheimer's disease and dementia risk in epilepsy patients. His work demonstrates significant global health dimensions, with research spanning from Tanzania to international collaborations. Methodologically, his publications include clinical trials, systematic reviews, ethnographic studies, and large-scale epidemiological analyses using UK Biobank data. Several publications address critical gaps in epilepsy care, including SUDEP research, equitable access to medications, and the impact of the COVID-19 pandemic on epilepsy care. Arjune Sen holds two major grants: 'The immunological basis of pharmacoresistance in epilepsy' (£1.3M from UCB Pharma), where he serves as PI alongside Sarosh Irani and Julian Knight 'Epilepsy Pathway Innovation in Africa (EPInA)' (£4.9M from NIHR), where he serves as Co-Chief Investigator with Charles Newton He leads the Oxford Epilepsy Research Group and the Centre for Global Epilepsy, and is deeply involved with the Oxford Martin Programme on Global Epilepsy. His clinical work includes running multidisciplinary clinics such as 'Epilepsy and learning disability' and 'Epilepsy and employment', ensuring his research remains grounded in clinical practice and patient-centered care.

Greg J. BashawView profile

Professor

• Neuroscience
• Developmental Biology
• Molecular Biology
• +3 more

Greg J. Bashaw is a Professor of Neuroscience at the Perelman School of Medicine, University of Pennsylvania. He directs a research lab focused on molecular mechanisms of axon growth and guidance, particularly at the nervous system midline. His work spans Drosophila embryonic CNS and mouse spinal cord systems, investigating evolutionary conserved pathways like Slit-Robo and Netrin-DCC. Education: B.A. in Biology from Brown University (1990), Ph.D. in Biological Sciences from Stanford University (1997) under Bruce Baker Key Research Areas: Axon guidance, neural circuit assembly, receptor signaling, transcriptional regulation, and developmental neuroscience His laboratory explores non-canonical receptor roles, transcriptional networks in motor connectivity, and receptor degradation pathways. Awards include the Jane Glick Memorial Graduate Student Teaching and Mentoring Award, NIH NINDS Research Program Award (R35), and NSF grant (IOS-1355181) supporting both research and science outreach. Recent publications highlight discoveries in Robo-WAVE complex interactions, human DCC variants in mirror movement disorders, and receptor trafficking mechanisms. Collaborative work with institutions like Harvard, Johns Hopkins, and Cold Spring Harbor Laboratory demonstrates interdisciplinary impact. Scientific Awards Jane Glick Memorial Graduate Student Teaching and Mentoring Award NIH NINDS Research Program Award (R35) NSF grant renewal (IOS-1355181) Louis Flexner Neuroscience Thesis Prize Tom Kadesch Genetics Thesis Prize Saul Winegrad Award for Outstanding Dissertation Training Legacy 15+ PhD graduates in neuroscience, genetics, and molecular biology Lab alumni now hold academic positions at Yale, Harvard, and international institutions NSF-funded DrosoPHILA outreach program with Philadelphia high schools

• Biomedical Engineering
• Neuroscience
• Neural Interfaces
• +3 more

Sebastian Markert is a Junior Professor with Tenure Track at the Saarland University of Applied Sciences, specializing in the interaction between neuronal tissue and technical systems as part of the Engineering faculty. He collaborates with Zeiss as an industrial partner and is based at the Goebenstraße 40 campus in Saarbrücken, Germany. His research bridges neuroscience and engineering to explore neural interfaces and bioengineering applications.

Jorge Gómez-DezaView profile

Assistant Professor

• Peripheral Neuropathy
• Chronic Pain
• Neurodegenerative Diseases
• +3 more

Jorge Gómez-Deza serves as Assistant Professor in the Department of Cancer and Cellular Biology at Temple University's Lewis Katz School of Medicine, with dual affiliation at Fox Chase Cancer Center. His research bridges molecular neuroscience and clinical oncology to address chemotherapy-induced neurotoxicity. His educational background includes: BSc in Biochemistry from University College London MRes in Translational Science from King's College London PhD in Basic and Clinical Neuroscience from King's College London The Gómez-Deza Lab employs iPSC-derived neurons , CRISPR screening , and advanced microscopy to investigate axon degeneration mechanisms. Research priorities include: Discovery of novel axon degeneration drivers CRISPRi screens of chemotherapy-induced neuron death pathways Development of neuroprotective inhibitors with applications spanning chemotherapy neuropathy, glaucoma, TBI, and ALS. Recent publications (2023-2024) reveal a methodological shift toward genome-wide CRISPR screens and mitochondrial dynamics analysis in chemotherapy models, while maintaining focus on translational therapeutic development for neurodegenerative conditions. His competitive funding portfolio includes: NICHD Early Career Award NCATS Research Project grant Milton-Safenowitz ALSA Postdoctoral Fellowship Motor Neurone Disease Association Short term grant Dr. Gómez-Deza emphasizes mentorship in a lab culture prioritizing mental well-being and work-life balance, training scientists through hands-on experience with cutting-edge neurodegeneration models. His grants specifically support therapeutic target identification for chemotherapy-induced peripheral neuropathy. The lab operates across Temple University and Fox Chase Cancer Center facilities, utilizing collaborative resources for in vivo and in vitro neurodegeneration modeling while maintaining a diverse, innovative team environment focused on clinical translation.

Miriam B. GoodmanView profile

Professor

• Neuroscience
• Molecular Biology
• Mechanotransduction
• +5 more

Miriam B. Goodman holds the Mrs. George A. Winzer Professorship of Cell Biology at Stanford University , with affiliations in the Department of Molecular and Cellular Physiology , Bio-X , and the Wu Tsai Neurosciences Institute . As Chair of the Molecular and Cellular Physiology Department (2017–present) and former Deputy Director of the Stanford Neuroscience Institute (2013–2017), she leads interdisciplinary research bridging neuroscience, biophysics, and molecular physiology . Education : Ph.D. in Neurobiology, The University of Chicago (1995) Sc.B. in Biochemistry, Brown University (1986) Her research focuses on molecular mechanotransduction using C. elegans to investigate touch sensation, temperature detection, and neuronal stress resilience . Key methodologies include quantitative behavioral analysis , CRISPR gene editing , and in vivo electrophysiology . Recent work explores mechanical forces in feeding through upconverting microgauges and chemosensory integration of plant-derived molecules. Her publications span neurobiological mechanisms , biomechanical sensor design , and ecological signal processing , with a 2025 Nature study on ingestible nanosensors and a 2024 Current Biology paper on mechanosensory complex organization . Scientific Awards : Distinguished Alumni Award, University of Chicago (2024) Landis Award for Outstanding Mentoring, NIH (2019) Michael and Kate Barany Award, Biophysical Society (2014) Klingenstein Fellow in Neuroscience (2005-2008) McKnight Scholar Award (2005-2008) Prize in Neurobiology, Eppendorf & Science (2004) As an advisor, she mentors doctoral candidates in the Biophysics , Molecular and Cellular Physiology , and Neurosciences Ph.D. programs , including Madeline Cooper and Caroline Arellano-Garcia. Her lab collaborates with UC San Diego's Vergassola Group on mechanosensory physics and Stanford Microsystems Lab on optical sensor design .

• Artificial Intelligence
• Neuroscience
• Circuits and Systems Theory

Neslihan Serap Şengör is a Professor at the Department of Electronics and Communication Engineering, Istanbul Technical University . Her work bridges Artificial Intelligence , Neuroscience , and Circuits and Systems Theory . Research areas include: Neuromorphic computing with Intel Loihi Basal ganglia and motor control modeling Spiking neural networks for hardware Cognitive process simulation Projects focus on: Hardware implementation of motor learning Computational models for Parkinson's disease Cortex structure simulation on neuromorphic chips Contact: sengorn@itu.edu.tr

Lukas KapiteinView profile

Professor

• Biophysics
• Cell Biology
• Neurobiology
• +8 more

Prof. Dr. Lukas C. Kapitein is a leading researcher in Cell Biology, Neurobiology and Biophysics at the Faculty of Science, Utrecht University . His work bridges physics and neuroscience to understand how cells maintain their shape and intracellular organization, particularly in neurons. Academic Affiliation: Full Professor of Molecular and Cellular Biophysics since 2018 Key Collaborations: Co-manages the Gravitation project IMAGINE! with Anna Akhmanova Research Focus: The lab investigates the neuronal cytoskeleton , emphasizing microtubule organization and motor protein dynamics. They develop advanced optical methods to map cytoskeletal architecture and design intracellular assays to probe motor-cargo interactions, linking these to neurodegenerative disease mechanisms. Awards: ERC Consolidator Grant (2018), ERC Starting Grant (2013), NWO VIDI (2013), NWO ALW-VENI (2011), Erasmus MC Fellowship (2011). Students: PhD students include Albert Serweta, Thijs Makaske, Jasper Schelt, and Varsha Mahapatra. The lab also features postdocs and technical staff in microscopy and protein engineering. Methods: Combines protein engineering , super-resolution microscopy (STED, Localization, Expansion), and mathematical modeling to resolve microtubule polarity, transport rules, and dendritic spine dynamics.

Korneel HensView profile

Research Fellow

• Drosophila Genetics
• Transcription Factors
• Gene Regulatory Networks
• +3 more

Korneel Hens is a Senior Research Fellow at Oxford Brookes University's School of Biological and Medical Sciences, specializing in Drosophila genetics and gene regulatory networks. His work bridges molecular biology, genomics, and evolutionary studies. Current project: TFTag (2022-2027, £1.14M BBSRC-funded) to create a Drosophila transcription factor library. Key collaborations: Biotechnology & Biological Sciences Research Council, interdisciplinary teams in neuroscience and genomics. Research focuses on: Transcriptional control mechanisms in Drosophila insulin-producing cells Apoptotic pathway evolution in aphids Functional characterization of gene regulatory networks Comparative studies between insect and human angiotensin-converting enzymes Chromatin dynamics during development Evolutionary conservation of molecular pathways His publications span top journals like Molecular Ecology , PLoS Genetics , and Cell Reports , with over 15 recent articles demonstrating sustained research productivity. Awards include significant BBSRC grant funding for large-scale Drosophila studies. Advising activities and student supervision details are not explicitly mentioned. He contributes to technical innovations like yeast one-hybrid screening methods and primer databases for qPCR.

Isaac KauvarView profile

Research Fellow

• Neuroscience
• Photonics
• Neurotechnology
• +3 more

Isaac Kauvar is a Postdoctoral Fellow at the Department of Electrical Engineering, School of Engineering, Stanford University. He holds a B.S. in Engineering Physics specializing in Photonics, an M.S. in Electrical Engineering focusing on Imaging and Optimization, and is currently pursuing a PhD in Electrical Engineering under the co-advisement of Prof. Gordon Wetzstein. Education B.S. Engineering Physics, Stanford M.S. Electrical Engineering, Stanford His research bridges Neuroscience, Photonics, and Computational Modeling to develop advanced imaging and neural activity measurement technologies. Key contributions include optical brain-computer interfaces, light-field microscopy innovations, and neural circuit analysis across species. Recent publications highlight work in cortical imaging, emotional response modeling, and neurotechnology development. His expertise spans optical systems design, neural dynamics analysis, and brain state modulation. Contact: ikauvar@stanford.edu

Michelle Mazei-RobisonView profile

Professor

• Neuroscience
• Psychiatric Disorders
• Addiction Research
• +7 more

Michelle Mazei-Robison is a Professor in the Department of Physiology at Michigan State University and faculty member in the Neuroscience Program, with an additional appointment as Associate Professor in the BioMolecular Science Gateway. Her research laboratory, located at 5017 766 Service Road, Room 5017, focuses on molecular mechanisms underlying psychiatric disorders including depression and addiction, utilizing the chronic social defeat mouse model to investigate the mesocorticolimbic dopamine system. Her primary research interests center on neuroadaptations in ventral tegmental area (VTA) dopamine neurons induced by stress and drugs of abuse. She investigates structural and functional changes in VTA neurons, signaling pathways altered by morphine/cocaine exposure, and subtype-specific responses within dopaminergic circuits. Her lab employs cutting-edge methodologies including optogenetics, viral-mediated gene transfer, 3D neuronal reconstruction, and behavioral assays to unravel mechanisms of depression and addiction. Analysis of her 2020-2025 publications reveals consistent focus on VTA neuronal subpopulations (particularly neuromedin S and GLP-1 expressing neurons), SGK1 kinase signaling in drug reward, and sex-specific stress responses. Her work demonstrates how molecular adaptations in dopamine neurons mediate morphine/cocaine behaviors while exploring hippocampal contributions to stress resilience through ΔFosB regulation. Scientific Awards: No awards were documented in the provided sources. Advising and Grants: The available materials list no specific students, grant awards, or mentoring activities. Her laboratory operations and publication record indicate active research funding, though exact mechanisms remain unspecified in the source texts. Labs and Teams: Dr. Mazei-Robison co-directs the Robison and Mazei-Robison Labs, which integrate mouse models, genetic engineering, electrophysiology, and advanced microscopy to study comorbid conditions like opiate abuse with PTSD. The lab bridges molecular mechanisms (gene expression, protein function) across multiple neural systems to explain behavioral outcomes in addiction and depression.

• Oncology
• Tumor Biology
• Cancer Immunology
• +3 more

Arne Östman is a Professor at the Department of Clinical Medicine, University of Bergen, with a focus on tumor biology and stromal cell interactions. His research explores the clinical significance of PDGF receptors and fibroblast-immune crosstalk in cancer progression. Research interests include: Stromal regulation of tumor growth and metastasis PDGF signaling in cancer biology Immune-stromal interactions in tumor microenvironments Biomarker development for cancer prognosis and therapy Recent publications examine cancer-associated fibroblasts in breast and liver metastases, T-cell interactions, and imaging mass cytometry applications. His work spans molecular mechanisms to clinical trial validations.